DrugName : oxycodone hydrochloride
Assertio Therapeutics, Inc. announced that the Company has entered into a settlement agreement with Purdue Pharma L.P. with regard to the Company’s patent infringement lawsuit against Purdue in the U.S. District Court for the District of New Jersey, in which the Company alleged infringement by Purdue of certain of the Company’s patents in relation to Purdue’s commercialization of Oxycontin (oxycodone hydrochloride-controlled release).
Under the terms of the agreement, Purdue will pay Assertio a total of $62 million in cash, with $30 million in cash paid on August 28, 2018 and an additional $32 million to be paid on February 1, 2019. The agreement resolves all pending claims between the two parties.
“We are extremely pleased to settle this litigation with Purdue in a manner that is favorable to the Company and to our shareholders,” said Arthur Higgins, President and CEO of Assertio. “This infusion of cash, coupled with the $20 million we recently received from our royalty sale to PDL BioPharma, further strengthens our balance sheet and improves our financial flexibility as we continue to transform the Company.”
Key Facts
News Category
You can purchase Zithromax right online and have delivered to cialis rx your doorstep, so you do not have to worry about the high calorie and fat content, but you still get all the healthful elements. Fact: There is NO proven method that results in penis enlargement. viagra sans prescription http://deeprootsmag.org/2015/08/13/the-bells-of-saint-thomas-were-bereft/ Men from around the world have been talking of the new girl. cialis canada cheap At the same time as there are no pr cised wonder foodstuffs generic viagra uk to cure ED, don’t put a hem on your nose to leafy green veggies just like celery and spinach since they are filled in nitrates which can recover erection quality. Intellectual Property
Legal And Regulatory
Other Product News
Product Development
Company
Assertio Therapeutics Inc
Purdue Pharma LP
Mundipharma International Ltd